‘Serial killers’: FDA panel recommends approving 1st gene-altering leukemia treatment

A Food and Drug Administration panel has approved the first-ever gene therapy to treat Leukemia. The immunotherapy works by genetically alters a patient’s own cells to fight cancer and bolsters the immune system to shut down the disease.
Read Full Article at RT.com